Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Botulinum toxin vs hyaluronic acid injections for knee osteoarthritis

Official title: Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis

Run by Tanta University · NCT07666347 · Data updated 2026-11-12

This study tests whether injecting botulinum toxin or hyaluronic acid directly into the knee provides better pain relief for people with knee osteoarthritis.

More Knee Osteoarthritis trials

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment50 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, El-Gharbia)
StatusRecruiting
StartedJune 24, 2026
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedJune 25, 2026
Trial IDNCT07666347 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50 and older with chronic knee OA (Kellgren-Lawrence grade 3–4) eligible for intra-articular injections.

Probably not a fit

Individuals with recent knee injections, significant comorbidities limiting participation, or BMI above 40 kg/m2 may have reduced benefit or be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two intra-articular injections—botulinum toxin type A and hyaluronic acid—in adults with knee osteoarthritis. Participants are 50 years or older and meet diagnostic criteria with moderate radiographic OA. The trial will assess pain outcomes after treatment to determine which injection offers more pain relief with an acceptable safety profile. The mechanism involves botulinum toxin reducing nerve signaling and hyaluronic acid aiming to improve joint lubrication, with patients followed for a defined period to evaluate efficacy and safety. The study is conducted at Tanta University in Egypt under a lead sponsorship with no listed collaborators.

Why it matters

Potential benefit: If successful, patients could experience better knee pain control from a single IA injection strategy.

How similar studies have gone: Previous research has explored IA hyaluronic acid with mixed results; this direct comparison to botulinum toxin is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 50 years.
* Both genders.
* Chronic knee osteoarthritis (KOA) according to American College of Rheumatology criteria for the diagnosis of knee osteoarthritis.
* Third or fourth grade Kellgren and Lawrence system for classification of osteoarthritis based on radiological data, it is a common method of classifying the severity of osteoarthritis (OA) using five grades according to the following sites and projections.

Exclusion Criteria:

* History of intra-articular injection within the last 6 months,
* History of surgery on the knee joint or major trauma to the lower limb causing fracture.
* Body mass index (BMI) more than 40 kg/m2.
* Medical conditions affecting the joint or lower extremity function such as severe osteoporosis, rheumatoid arthritis, collagen vascular diseases, and gout.
* Diabetic patient.
* Any contraindication to intra-articular injections for instance immunodeficiency, coagulation defect or anticoagulation therapy taking or skin infection at the site of injection.
* Hypersensitivity to Botulinum toxin or hyaluronic acid.

Where it's running

  • Tanta University
    Tanta, El-Gharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.